Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oral therapy for multiple sclerosis--sea change or incremental step?

× No keyword cloud information.

12 in total

Review 1. Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.

Authors: Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Journal: Br J Pharmacol Date: 2012-04 Impact factor: 8.739

Review 2. Interferon-β-1b: a review of its use in multiple sclerosis.

Authors: Greg L Plosker
Journal: CNS Drugs Date: 2011-01 Impact factor: 5.749

3. New hope for multiple sclerosis patients.

Authors: Craig W Lindsley
Journal: ACS Chem Neurosci Date: 2013-03-20 Impact factor: 4.418

Review 4. Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.

Authors: Natalie J Carter; Gillian M Keating
Journal: Drugs Date: 2010-08-20 Impact factor: 9.546

5. Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.

Authors: Ying Wang; Lu Cao; Li-Min Xu; Fan-Fan Cao; Bin Peng; Xue Zhang; Yu-Fan Shen; Georges Uzan; Deng-Hai Zhang
Journal: J Neuroimmune Pharmacol Date: 2015-03-15 Impact factor: 4.147

Review 6. Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine.

Authors: Clemens Warnke; Heinz Wiendl; Hans-Peter Hartung; Olaf Stüve; Bernd C Kieseier
Journal: Drug Des Devel Ther Date: 2010-07-21 Impact factor: 4.162

7. Dynamic Learning of Patient Response Types: An Application to Treating Chronic Diseases.

Authors: Diana M Negoescu; Kostas Bimpikis; Margaret L Brandeau; Dan A Iancu
Journal: Manage Sci Date: 2017-08-21 Impact factor: 4.883

8. MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?

Authors: Susan Worley
Journal: Biotechnol Healthc Date: 2012

9. Expression of leukotriene B₄ receptor 1 defines functionally distinct DCs that control allergic skin inflammation.

Authors: Tomoaki Koga; Fumiyuki Sasaki; Kazuko Saeki; Soken Tsuchiya; Toshiaki Okuno; Mai Ohba; Takako Ichiki; Satoshi Iwamoto; Hirotsugu Uzawa; Keiko Kitajima; Chikara Meno; Eri Nakamura; Norihiro Tada; Yoshinori Fukui; Junichi Kikuta; Masaru Ishii; Yukihiko Sugimoto; Mitsuyoshi Nakao; Takehiko Yokomizo
Journal: Cell Mol Immunol Date: 2020-10-09 Impact factor: 11.530

10. Prevalence of celiac disease in multiple sclerosis.

Authors: Luis Rodrigo; Carlos Hernández-Lahoz; Dolores Fuentes; Noemí Alvarez; Antonio López-Vázquez; Segundo González
Journal: BMC Neurol Date: 2011-03-07 Impact factor: 2.474

Oral therapy for multiple sclerosis--sea change or incremental step?